4.6 Article

Alternative Activation Mechanisms of Protein Kinase B Trigger Distinct Downstream Signaling Responses

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 290, 期 41, 页码 24975-24985

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M115.651570

关键词

-

资金

  1. Spanish Ministry of Economy and Competitiveness [BFU2010-15923, SAF2010-18518]
  2. Comunidad Autonoma de Madrid [S2010/BMD-2457]
  3. National Cancer Research Centre
  4. La Caixa Foundation
  5. Caja Navara postdoctoral fellowship
  6. Sever Ochoa funds
  7. Spanish Ramon y Cajal fellowship
  8. Ramon y Cajal Program [RYC-2010-06948]
  9. Volkswagen Foundation [Az: 86 416-1]

向作者/读者索取更多资源

Protein kinase B (PKB/Akt) is an important mediator of signals that control various cellular processes including cell survival, growth, proliferation, and metabolism. PKB promotes these processes by phosphorylating many cellular targets, which trigger distinct downstream signaling events. However, how PKB is able to selectively target its substrates to induce specific cellular functions remains elusive. Here we perform a systematic study to dissect mechanisms that regulate intrinsic kinase activity versus mechanisms that specifically regulate activity toward specific substrates. We demonstrate that activation loop phosphorylation and the C-terminal hydrophobic motif are essential for high PKB activity in general. On the other hand, we identify membrane targeting, which for decades has been regarded as an essential step in PKB activation, as a mechanism mainly affecting substrate selectivity. Further, we show that PKB activity in cells can be triggered independently of PI3K by initial hydrophobic motif phosphorylation, presumably through a mechanism analogous to other AGC kinases. Importantly, different modes of PKB activation result in phosphorylation of distinct downstream targets. Our data indicate that specific mechanisms have evolved for signaling nodes, like PKB, to select between various downstream events. Targeting such mechanisms selectively could facilitate the development of therapeutics that might limit toxic side effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis

Lucia Zhu, Diana Retana, Pedro Garcia-Gomez, Laura Alvaro-Espinosa, Neibla Priego, Mariam Masmudi-Martin, Natalia Yebra, Lauritz Miarka, Elena Hernandez-Encinas, Carmen Blanco-Aparicio, Sonia Martinez, Cecilia Sobrino, Nuria Ajenjo, Maria-Jesus Artiga, Eva Ortega-Paino, Raul Torres-Ruiz, Sandra Rodriguez-Perales, Riccardo Soffietti, Luca Bertero, Paola Cassoni, Tobias Weiss, Javier Munoz, Juan Manuel Sepulveda, Pedro Gonzalez-Leon, Luis Jimenez-Roldan, Luis Miguel Moreno, Olga Esteban, Angel Perez-Nunez, Aurelio Hernandez-Lain, Oscar Toldos, Yolanda Ruano, Lucia Alcazar, Guillermo Blasco, Jose Fernandez-Alen, Eduardo Caleiras, Miguel Lafarga, Diego Megias, Osvaldo Grana-Castro, Carolina Nor, Michael D. Taylor, Leonie S. Young, Damir Vareslija, Nicola Cosgrove, Fergus J. Couch, Lorena Cusso, Manuel Desco, Silvana Mouron, Miguel Quintela-Fandino, Michael Weller, Joaquin Pastor, Manuel Valiente

Summary: We report a medium-throughput drug-screening platform based on organotypic cultures that evaluates inhibitors against metastases growing in situ. Through this approach applied to brain metastasis, vulnerabilities were identified and a blood-brain barrier permeable HSP90 inhibitor was found to be effective against mouse and human brain metastases. In situ proteomic analysis revealed a novel molecular program in brain metastasis and potential biomarkers of poor prognosis and resistance mechanisms. This study validates METPlatform as a potent resource for metastasis research and personalized management of metastatic disease.

EMBO MOLECULAR MEDICINE (2022)

Article Gastroenterology & Hepatology

Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis

Amanda Garrido, Eunjeong Kim, Ana Teijeiro, Paula Sanchez Sanchez, Rosa Gallo, Ajay Nair, Maria Matamala Montoya, Cristian Perna, Guillermo P Vicent, Javier Munoz, Ramon Campos-Olivas, Johannes C. Melms, Benjamin Izar, Robert F. Schwabe, Nabil Djouder

Summary: This study reveals the critical role of MCRS1 in the pathogenesis of cirrhosis, shedding light on potential new treatment strategies for the disease.

JOURNAL OF HEPATOLOGY (2022)

Article Chemistry, Medicinal

TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy

Vanesa Nozal, Loreto Martinez-Gonzalez, Marta Gomez-Almeria, Claudia Gonzalo-Consuegra, Paula Santana, Apirat Chaikuad, Eva Perez-Cuevas, Stefan Knapp, Daniel Lietha, David Ramirez, Sabrina Petralla, Barbara Monti, Carmen Gil, Angeles Martin-Requero, Valle Palomo, Eva de Lago, Ana Martinez

Summary: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the aggregation of protein TDP-43. In this study, TTBK1 inhibitors were identified as a promising therapeutic strategy for ALS. The novel pyrrolopyrimidine derivatives demonstrated their ability to reduce TDP-43 phosphorylation and preserve motor neurons in mouse models, suggesting their potential for future ALS therapy.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biology

Structural basis of Nrd1- Nab3 heterodimerization

Belen Chaves-Arquero, Santiago Martinez-Lumbreras, Sergio Camero, Clara M. Santiveri, Yasmina Mirassou, Ramon Campos-Olivas, Maria Angeles Jimenez, Olga Calvo, Jose Manuel Perez-Canadillas

Summary: Heterodimerization of RNA binding proteins Nrd1 and Nab3 is crucial for yeast cell fitness, and the structure of Nrd1-Nab3 resembles that of Rna14/Rna15 despite sequence and evolutionary differences.

LIFE SCIENCE ALLIANCE (2022)

Review Cell Biology

New insights into FAK structure and function in focal adhesions

Johanne Le Coq, Ivan Acebron, Barbara Rodrigo Martin, Pilar Lopez Navajas, Daniel Lietha

Summary: In this review, the authors discuss the role of focal adhesion kinase (FAK) in cell-matrix adhesion and migration. They highlight the known structural features of FAK and the challenges in understanding its integration in the focal adhesion complex and the structural changes during focal adhesion maturation.

JOURNAL OF CELL SCIENCE (2022)

Article Immunology

Transit-amplifying cells control R-spondins in the mouse crypt to modulate intestinal stem cell proliferation

Almudena Chaves-Perez, Karla Santos-de-Frutos, Sergio de la Rosa, Irene Herranz-Montoya, Cristian Perna, Nabil Djouder

Summary: This study reveals the important role of transit-amplifying cells in controlling inflammatory signals and R-spondin production, which are essential for maintaining intestinal stem cell proliferation and tissue regeneration.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation

Sara Garcia-Alonso, Pablo Mesa, Laura de la Puente Ovejero, Gonzalo Aizpurua, Carmen G. Lechuga, Eduardo Zarzuela, Clara M. Santiveri, Manuel Sanclemente, Javier Munoz, Monica Musteanu, Ramon Campos-Olivas, Jorge Martinez-Torrecuadrada, Mariano Barbacid, Guillermo Montoya

Summary: This study describes the structure of the RAF1 protein in complex with HSP90 and CDC37. The research reveals that CDC37 can differentiate between different members of the RAF family. Additionally, the study shows that folded RAF1 assembles with 14-3-3 dimers, and disrupting the interaction between CDC37 and RAF1 may have potential therapeutic implications.

MOLECULAR CELL (2022)

Article Biochemistry & Molecular Biology

The MASTL/PP2A cell cycle kinase-phosphatase module restrains PI3K-Akt activity in an mTORC1-dependent manner

Belen Sanz-Castillo, Begona Hurtado, Diana Vara-Ciruelos, Aicha El Bakkali, Dario Hermida, Beatriz Salvador-Barbero, Diego Martinez-Alonso, Jose Gonzalez-Martinez, Clara Santiveri, Ramon Campos-Olivas, Pilar Ximenez-Embun, Javier Munoz, Monica Alvarez-Fernandez, Marcos Malumbres

Summary: This study reveals that the cell cycle kinase MASTL/Greatwall inhibits the activity of the PI3K-AKT signaling pathway by phosphorylating the PP2A/B55 inhibitor ENSA/ARPP19, thus limiting AKT activity. Furthermore, the study finds that MASTL is directly phosphorylated by mTORC1, which limits the dephosphorylation of IRS1 and GRB10 downstream of mTORC1, further restraining AKT activity. This research highlights the importance of the MASTL-PP2A/B55 kinase-phosphatase module in controlling AKT and maintaining metabolic homeostasis.

EMBO JOURNAL (2023)

Editorial Material Multidisciplinary Sciences

A mechanistic view of the use of cold temperature in the treatment of cancer

Tatiana P. Grazioso, Nabil Djouder

Summary: In their latest article, Seki and colleagues investigate the potential role of cold exposure in treating various cancer types, including untreatable ones like pancreatic cancer. They suggest that cold exposure may suppress tumor growth by activating brown adipose tissue (BAT), which dissipates heat through non-shivering thermogenesis. This leads to decreased circulating blood glucose, limiting tumor glucose uptake and favoring BAT uptake for thermogenesis.

ISCIENCE (2023)

Review Biochemistry & Molecular Biology

Dietary interventions and precision nutrition in cancer therapy

Carlos Martinez-Garay, Nabil Djouder

Summary: In recent years, dietary interventions have shown promise in cancer treatment by influencing metabolism, tumor growth, development, and therapeutic response. However, due to a lack of understanding in the mechanisms behind dietary therapeutics, they are often overlooked as a potential line of cancer treatment. This review aims to provide a comprehensive overview of the anticancer effects of various diets and their development for clinical use, with the goal of establishing nutritional interventions as a standard treatment.

TRENDS IN MOLECULAR MEDICINE (2023)

Review Multidisciplinary Sciences

The forgotten art of cold therapeutic properties in cancer: A comprehensive historical guide

Tatiana P. Grazioso, Nabil Djouder

Summary: Cold therapy, a powerful therapeutic approach that has been used for centuries, has been largely forgotten in modern medicine. This review explores its history and potential application in treating various diseases, including cancer, through techniques like cryoablation, cryotherapy, cryoimmunotherapy, cryothalectomy, and cryogen agent delivery. Although clinical trials are limited, recent research shows promising results in experimental animal cancer models, highlighting the significance of further investigation.

ISCIENCE (2023)

Review Oncology

Is liver regeneration key in hepatocellular carcinoma

Maria del Mar Rigual, Paula Sanchez Sanchez, Nabil Djouder

Summary: The liver, as the largest organ in mammals, has the ability to fully regenerate for tissue homeostasis. However, stress signals can impair liver regeneration and contribute to the development of hepatocellular carcinoma (HCC), a highly aggressive liver cancer. This review discusses the mechanisms of hepatic regeneration and their potential role in HCC development.

TRENDS IN CANCER (2023)

Meeting Abstract Biophysics

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions

Magnus S. Bauer, Sophia Gruber, Adina Hausch, Lukas F. Milles, Thomas Nicolaus, Leonard C. Schendel, Pilar Lopez Navajas, Erik Procko, Daniel Lietha, Rafael C. Bernardi, Jan Lipfert, Hermann E. Gaub

BIOPHYSICAL JOURNAL (2022)

暂无数据